US private equity firm Bain Capital has agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit Mitsubishi Tanabe ...

US investment group Bain Capital has agreed to buy Mitsubishi Tanabe Pharma for JPY 510 billion (around $3.4 billion), setting up one of the largest private equity buyouts in Japan's healthcare ...

Bain Capital LP has entered into a definitive agreement with ... Following the closing of the transaction, Tanabe Pharma will continue to develop innovative medical technologies to enhance research ...

TOKYO & BOSTON--(BUSINESS WIRE)--Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ...

In the latest in a growing trend of pharma reshuffling moves in Asia, Marubeni Corporation is absorbing Sumitomo Pharma’s ...

HONG KONG] Bain Capital is looking to raise billions of US dollars for its next Asia fund and a special situation fund in the region, as it moves to back private equity (PE) and credit deals in ...

Mumbai: Global private equity firm Bain Capital is looking to divest its stake in listed pharmaceutical manufacturer Emcure Pharmaceuticals Ltd through a substantial block deal, according to two ...

JERSEY CITY, N.J., April 3, 2025 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) announced 11 presentations will be shared at the American Academy of Neurology (AAN) 2025 Annual ...